Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas. (Q47254055)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Blaise A Clarke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

David Bowtell

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

15

Sarah Ferguson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

25

Jessica N McAlpine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

23

David G Huntsman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

10

Steve E Kalloger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

24

C Blake Gilks

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

5

Laura Galletta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

8

Sian Fereday

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

13

Helen Steed

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

2

Stefan Kommoss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

11

Janine Senz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

21

Anna V Tinker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Mary C Tolcher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Henry Porter

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sambasivarao Damaraju

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Boris J Winterhoff

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Winnie Yang

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Ghassan Allo

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Patricia Shaw

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Attila Teoman

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Joaquin J Garcia

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

John K Schoolmeester

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jamie Bakkum-Gamez

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

1 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

111-120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data

11 February 2020

cites work

1 reference

Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis.

21 January 2018

1 reference

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

21 January 2018

1 reference

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

21 January 2018

1 reference

Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment.

21 January 2018

1 reference

Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer

21 January 2018

1 reference

Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.

21 January 2018

1 reference

Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study.

21 January 2018

1 reference

Targeting SRC in mucinous ovarian carcinoma.

21 January 2018

1 reference

Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy

21 January 2018

1 reference

Molecular characterization of 103 ovarian serous and mucinous tumors.

21 January 2018

1 reference

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

21 January 2018

1 reference

Calculator for ovarian carcinoma subtype prediction

21 January 2018

1 reference

Molecular characterization of a new ovarian cancer cell line, YDOV-151, established from mucinous cystadenocarcinoma.

21 January 2018

1 reference

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

21 January 2018

1 reference

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.

21 January 2018

1 reference

Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer.

21 January 2018

1 reference

BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas

21 January 2018

1 reference

Silver in situ hybridization (SISH) for determination of HER2 gene status in breast carcinoma: comparison with FISH and assessment of interobserver reproducibility.

21 January 2018

1 reference

Emerging technologies for assessing HER2 amplification

21 January 2018

1 reference

HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment.

21 January 2018

1 reference

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

21 January 2018

1 reference

Reproductive Factors and Epithelial Ovarian Cancer Risk by Histologic Type:A Multiethnic Case-Control Study

21 January 2018

1 reference

Strategy for randomised clinical trials in rare cancers

21 January 2018

1 reference

Clinical trials and rare diseases: a way out of a conundrum

21 January 2018

1 reference

Oncogenic mutations as predictive factors in colorectal cancer

21 January 2018

1 reference

Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer.

21 January 2018

1 reference

Mechanisms of resistance to epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small-cell lung cancer: clinical and molecular considerations

21 January 2018

1 reference

All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer

21 January 2018

1 reference

Systematic review: Anti-epidermal growth factor receptor treatment effect modification by KRAS mutations in advanced colorectal cancer

21 January 2018

1 reference

Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma

21 January 2018

1 reference

Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?

21 January 2018

1 reference

The long and winding road to useful predictive factors for anti-EGFR therapy in metastatic colorectal carcinoma: the KRAS/BRAF pathway

21 January 2018

1 reference

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

21 January 2018

1 reference

21 January 2018

Mucinous ovarian cancer

1 reference

Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybrid

21 January 2018

1 reference

Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.4088

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899400%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference